Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

The use of p16/Ki-67 dual staining technology on cervical cytology of patients undergoing a LLETZ procedure.

Packet B, Poppe W, Weynand B, Vanherck M.

Eur J Obstet Gynecol Reprod Biol. 2018 Jun 21;228:191-196. doi: 10.1016/j.ejogrb.2018.06.025. [Epub ahead of print]

PMID:
30007246
2.

Pregnancy outcome after cervical conisation: A 2nd retrospective cohort study in the Leuven University Hospital.

van Velthoven K, Poppe W, Verschuere H, Arbyn M.

Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:224-231. doi: 10.1016/j.ejogrb.2017.06.043. Epub 2017 Jun 29.

PMID:
28822944
3.

Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.

Garland SM, Paavonen J, Jaisamrarn U, Naud P, Salmerón J, Chow SN, Apter D, Castellsagué X, Teixeira JC, Skinner SR, Hedrick J, Limson G, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Del Rosario-Raymundo MR, Catteau G, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Int J Cancer. 2016 Dec 15;139(12):2812-2826. doi: 10.1002/ijc.30391. Epub 2016 Sep 9.

4.

Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndrome.

Moens L, Frans G, Bosch B, Bossuyt X, Verbinnen B, Poppe W, Boeckx N, Slatter M, Brusselmans C, Diaz G, Tousseyn T, Flipts H, Corveleyn A, Dierickx D, Meyts I.

J Allergy Clin Immunol. 2016 Nov;138(5):1485-1489.e2. doi: 10.1016/j.jaci.2016.04.057. Epub 2016 Jul 12. No abstract available.

PMID:
27484033
5.

Surveillance of effects of HPV vaccination in Belgium.

Arbyn M, Broeck DV, Benoy I, Bogers J, Depuydt C, Praet M, Sutter PD, Hoorens A, Hauben E, Poppe W, Van Ranst M, Delvenne P, Gofflot S, Pétein M, Engelen F, Vanneste A, Beeck LO, Damme PV, Temmerman M, Weyers S.

Cancer Epidemiol. 2016 Apr;41:152-8. doi: 10.1016/j.canep.2015.12.011. Epub 2016 Feb 16.

PMID:
26895623
6.
7.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

Kreimer AR, Struyf F, Del Rosario-Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM; Costa Rica Vaccine Trial Study Group Authors, González P, Jiménez S, Lowy DR, Pinto LA, Porras C, Rodriguez AC, Safaeian M, Schiffman M, Schiller JT, Schussler J, Sherman ME; PATRICIA Study Group Authors, Bosch FX, Castellsague X, Chatterjee A, Chow SN, Descamps D, Diaz-Mitoma F, Dubin G, Germar MJ, Harper DM, Lewis DJ, Limson G, Naud P, Peters K, Poppe WA, Ramjattan B, Romanowski B, Salmeron J, Schwarz TF, Teixeira JC, Tjalma WA; HPV PATRICIA Principal Investigators/Co-Principal Investigator Collaborators; GSK Vaccines Clinical Study Support Group.

Lancet Oncol. 2015 Jul;16(7):775-86. doi: 10.1016/S1470-2045(15)00047-9. Epub 2015 Jun 9.

8.

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.

Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, Naud P, Salmerón J, Chow SN, Kitchener HC, Teixeira JC, Jaisamrarn U, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Mindel A, de Sutter P, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Clin Vaccine Immunol. 2015 Apr;22(4):361-73. doi: 10.1128/CVI.00591-14. Epub 2015 Feb 4.

9.

[The use of intrauterine device in nulliparous over 18 years: a Belgian consensus].

Gaspard U, Verguts J, Simon P, Depypere H, Merckx M, Loquet P, Walravens F, Firquet A, Poppe W, Leunen M, Donders G, Squifflet J, Grandjean P.

J Pharm Belg. 2014 Dec;(4):28-35. French.

PMID:
25562925
10.

Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.

Struyf F, Colau B, Wheeler CM, Naud P, Garland S, Quint W, Chow SN, Salmerón J, Lehtinen M, Del Rosario-Raymundo MR, Paavonen J, Teixeira JC, Germar MJ, Peters K, Skinner SR, Limson G, Castellsagué X, Poppe WA, Ramjattan B, Klein TD, Schwarz TF, Chatterjee A, Tjalma WA, Diaz-Mitoma F, Lewis DJ, Harper DM, Molijn A, van Doorn LJ, David MP, Dubin G; HPV PATRICIA Study Group.

Clin Vaccine Immunol. 2015 Feb;22(2):235-44. doi: 10.1128/CVI.00457-14. Epub 2014 Dec 24.

11.

Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study.

Aerts L, Enzlin P, Verhaeghe J, Poppe W, Vergote I, Amant F.

J Sex Med. 2015 Jan;12(1):198-209. doi: 10.1111/jsm.12764. Epub 2014 Nov 17.

PMID:
25402322
12.

Long-term sexual functioning in women after surgical treatment of cervical cancer stages IA to IB: a prospective controlled study.

Aerts L, Enzlin P, Verhaeghe J, Poppe W, Vergote I, Amant F.

Int J Gynecol Cancer. 2014 Oct;24(8):1527-34. doi: 10.1097/IGC.0000000000000236.

PMID:
25180463
13.

Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.

Castellsagué X, Naud P, Chow SN, Wheeler CM, Germar MJ, Lehtinen M, Paavonen J, Jaisamrarn U, Garland SM, Salmerón J, Apter D, Kitchener H, Teixeira JC, Skinner SR, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Peters K, Tjalma WA, Safaeian M, Raillard A, Descamps D, Struyf F, Dubin G, Rosillon D, Baril L.

J Infect Dis. 2014 Aug 15;210(4):517-34. doi: 10.1093/infdis/jiu139. Epub 2014 Mar 8.

14.

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.

Castellsagué X, Paavonen J, Jaisamrarn U, Wheeler CM, Skinner SR, Lehtinen M, Naud P, Chow SN, Del Rosario-Raymundo MR, Teixeira JC, Palmroth J, de Carvalho NS, Germar MJ, Peters K, Garland SM, Szarewski A, Poppe WA, Romanowski B, Schwarz TF, Tjalma WA, Bosch FX, Bozonnat MC, Struyf F, Dubin G, Rosillon D, Baril L; HPV PATRICIA Study Group.

BMC Infect Dis. 2014 Oct 30;14:551. doi: 10.1186/s12879-014-0551-y.

15.

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.

Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, Wheeler CM, Salmerón J, Chow SN, Apter D, Teixeira JC, Skinner SR, Hedrick J, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Paavonen J, Bozonnat MC, Descamps D, Struyf F, Dubin GO, Rosillon D, Baril L; HPV PATRICIA Study Group.

PLoS One. 2013 Nov 19;8(11):e79260. doi: 10.1371/journal.pone.0079260. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/cea59317-929c-464a-b3f7-e095248f229a.

16.

Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.

Szarewski A, Skinner SR, Garland SM, Romanowski B, Schwarz TF, Apter D, Chow SN, Paavonen J, Del Rosario-Raymundo MR, Teixeira JC, De Carvalho NS, Castro-Sanchez M, Castellsagué X, Poppe WA, De Sutter P, Huh W, Chatterjee A, Tjalma WA, Ackerman RT, Martens M, Papp KA, Bajo-Arenas J, Harper DM, Torné A, David MP, Struyf F, Lehtinen M, Dubin G.

J Infect Dis. 2013 Nov 1;208(9):1391-6. doi: 10.1093/infdis/jit360.

17.

The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening.

Hoste G, Vossaert K, Poppe WA.

Obstet Gynecol Int. 2013;2013:610373. doi: 10.1155/2013/610373. Epub 2013 Jul 1.

18.

2D versus 3D roadmap for uterine artery catheterization: impact on several angiographic parameters.

Maleux G, Michielsen K, Timmerman D, Poppe W, Heye S, Vaninbroukx J, Bosmans H.

Acta Radiol. 2014 Feb;55(1):62-70. doi: 10.1177/0284185113492457. Epub 2013 Jul 19.

PMID:
23873889
19.

Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.

Roset Bahmanyar E, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Skinner SR, Jaisamrarn U, Limson GA, Garland SM, Szarewski A, Romanowski B, Aoki F, Schwarz TF, Poppe WA, De Carvalho NS, Harper DM, Bosch FX, Raillard A, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Gynecol Oncol. 2012 Dec;127(3):440-50. doi: 10.1016/j.ygyno.2012.08.033. Epub 2012 Aug 30.

20.

Sexual, psychological, and relational functioning in women after surgical treatment for vulvar malignancy: a literature review.

Aerts L, Enzlin P, Vergote I, Verhaeghe J, Poppe W, Amant F.

J Sex Med. 2012 Feb;9(2):361-71. doi: 10.1111/j.1743-6109.2011.02520.x. Epub 2011 Nov 14. Review.

PMID:
22082135
21.

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David MP, Descamps D, Struyf F, Dubin G; HPV PATRICIA Study Group.

Lancet Oncol. 2012 Jan;13(1):89-99. doi: 10.1016/S1470-2045(11)70286-8. Epub 2011 Nov 8. Erratum in: Lancet Oncol. 2012 Jan;13(1):e1.

PMID:
22075171
22.

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Teixeira JC, Skinner SR, Jaisamrarn U, Limson G, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Harper DM, Huh W, Hardt K, Zahaf T, Descamps D, Struyf F, Dubin G, Lehtinen M; HPV PATRICIA Study Group.

Lancet Oncol. 2012 Jan;13(1):100-10. doi: 10.1016/S1470-2045(11)70287-X. Epub 2011 Nov 8. Erratum in: Lancet Oncol. 2012 Jan;13(1):e1.

PMID:
22075170
23.

Peritoneal "pearl" mystery after uterine artery embolization.

Cate DT, Poppe W, Moerman P, Maleux G.

J Vasc Interv Radiol. 2011 Oct;22(10):1491-3. doi: 10.1016/j.jvir.2011.06.024. No abstract available.

PMID:
21961986
24.

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.

Szarewski A, Poppe WA, Skinner SR, Wheeler CM, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Hedrick J, Jaisamrarn U, Limson G, Garland S, Romanowski B, Aoki FY, Schwarz TF, Bosch FX, Harper DM, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Int J Cancer. 2012 Jul 1;131(1):106-16. doi: 10.1002/ijc.26362. Epub 2011 Oct 23.

25.

Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices.

Enzlin P, Weyers S, Janssens D, Poppe W, Eelen C, Pazmany E, Elaut E, Amy JJ.

J Sex Med. 2012 Apr;9(4):1065-73. doi: 10.1111/j.1743-6109.2011.02266.x. Epub 2011 Apr 14.

PMID:
21492401
26.

Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.

Heymans J, Benoy IH, Poppe W, Depuydt CE.

Int J Cancer. 2011 Aug 15;129(4):903-9. doi: 10.1002/ijc.25745. Epub 2011 Feb 11.

27.

Why consider human papillomavirus vaccination in older women?

Poppe WA, Simon PH, De Ridder MR.

Gynecol Obstet Invest. 2010;70(4):237-43. doi: 10.1159/000314012. Epub 2010 Oct 16.

PMID:
21051842
28.

Pregnancy outcome after cervical conisation: a retrospective cohort study in the Leuven University Hospital.

van de Vijver A, Poppe W, Verguts J, Arbyn M.

BJOG. 2010 Feb;117(3):268-73. doi: 10.1111/j.1471-0528.2009.02437.x. Epub 2009 Nov 26.

29.

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G; HPV PATRICIA Study Group.

Lancet. 2009 Jul 25;374(9686):301-14. doi: 10.1016/S0140-6736(09)61248-4. Epub 2009 Jul 6. Erratum in: Lancet. 2010 Sep 25;376(9746):1054.

PMID:
19586656
30.

Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.

Neven P, Amant F, Poppe W, Van den Broecke R.

Fertil Steril. 2009 Apr;91(4):e5; author reply e6. doi: 10.1016/j.fertnstert.2008.12.067. Epub 2009 Feb 27. No abstract available.

PMID:
19249759
31.

[Should the antipapillomavirus vaccination after the age of 25 be advised?].

Simon P, Poppe W.

J Gynecol Obstet Biol Reprod (Paris). 2008 Dec;37(8):748-52. doi: 10.1016/j.jgyn.2008.07.003. Epub 2008 Aug 26. Review. French.

32.

Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study.

Schockaert S, Poppe W, Arbyn M, Verguts T, Verguts J.

Am J Obstet Gynecol. 2008 Aug;199(2):113.e1-5. doi: 10.1016/j.ajog.2008.02.026. Epub 2008 May 23. Review.

PMID:
18456229
33.

Aggressive angiomyxoma of the vulva: a case report and review of literature.

Dierickx I, Deraedt K, Poppe W, Verguts J.

Arch Gynecol Obstet. 2008 Jun;277(6):483-7. doi: 10.1007/s00404-008-0561-3. Review.

PMID:
18214507
34.

Re: "Pathologic risk factors for predicting residual disease in subsequent hysterectomy following LEEP conization".

Verguts J, Schockaert S, Moerman P, Poppe W.

Gynecol Oncol. 2007 Jul;106(1):273. Epub 2007 May 2. No abstract available.

PMID:
17477960
35.

European Union support for a Turkish reproductive health project to assess alternative cervical cancer screening methods in Sanliurfa (rural south-east Turkey).

Arbyn M, Tulunay G, Ozgul N, Yalvac S, Verguts J, Poppe W, Sankaranarayanan R.

Eur J Cancer Prev. 2006 Dec;15(6):552-3. No abstract available.

PMID:
17106338
36.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

37.
38.

Nitroimidazole-resistant vaginal trichomoniasis treated with paromomycin.

Poppe WA.

Eur J Obstet Gynecol Reprod Biol. 2001 May;96(1):119-20.

PMID:
11311775
39.

An intracranial tumour--an uncommon cause of hyperemesis in pregnancy.

Van Calenbergh SG, Poppe WA, Van Calenbergh F.

Eur J Obstet Gynecol Reprod Biol. 2001 Apr;95(2):182-3.

PMID:
11301166
40.

Lymphocytes and dendritic cells in the normal uterine cervix. An immunohistochemical study.

Poppe WA, Drijkoningen M, Ide PS, Lauweryns JM, Van Assche FA.

Eur J Obstet Gynecol Reprod Biol. 1998 Dec;81(2):277-82.

PMID:
9989877
41.

Cervical cotinine and macrophage-Langerhans cell density in the normal human uterine cervix.

Poppe WA, Peeters R, Drijkoningen M, Ide PS, Daenens P, Lauweryns JM, Van Assche FA.

Gynecol Obstet Invest. 1996;41(4):253-9.

PMID:
8793496
42.

Langerhans' cells and L1 antigen expression in normal and abnormal squamous epithelium of the cervical transformation zone.

Poppe WA, Drijkoningen M, Ide PS, Lauweryns JM, Van Assche FA.

Gynecol Obstet Invest. 1996;41(3):207-13.

PMID:
8698268
43.

Carbon dioxide laser for laparoscopic enterocele repair.

Koninckx PR, Poppe W, Deprest J.

J Am Assoc Gynecol Laparosc. 1995 Feb;2(2):181-5.

PMID:
9050554
44.

Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study.

Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, Van Assche FA.

Gynecol Obstet Invest. 1995;39(1):34-8.

PMID:
7890250
45.

Tobacco smoking and the uterine cervix: cotinine in blood, urine and cervical fluid.

Poppe WA, Peeters R, Daenens P, Ide PS, Van Assche FA.

Gynecol Obstet Invest. 1995;39(2):110-4.

PMID:
7737579
46.

Multicenter evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma.

Rosalki SB, Foo AY, Burlina A, Prellwitz W, Stieber P, Neumeier D, Klein G, Poppe WA, Bodenmüller H.

Clin Chem. 1993 Apr;39(4):648-52.

47.
49.

Successful pregnancy after selective embolization of a post-molar vascular malformation.

Poppe W, van Assche A.

Br J Obstet Gynaecol. 1989 May;96(5):623. No abstract available.

PMID:
2757986
50.

Evaluation of a new assay for pancreatic amylase: performance characteristics and estimation of reference intervals.

Junge W, Troge B, Klein G, Poppe W, Gerber M.

Clin Biochem. 1989 Apr;22(2):109-14.

PMID:
2470532

Supplemental Content

Support Center